Skip to main content
Indian stocks: Visit www.stage2stocks.com →

West Pharmaceutical Services, Inc.

Stage 2 · Advancing · week 24

As of Oct 22, 2026, West Pharmaceutical Services is in Stage 2, the uptrend phase, now in week 24 (since May 5, 2026). It closed at $394.03, at its 52-week high and above its 200-day average, which is rising.

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. More about the company

$394.03
+0.14% today
$27.7B · Large cap
Market Neutral — Building

Pro read

Pro

Our read

In Stage 2, but it has already run

Setup score

—

Momentum

Steady

Edge

—

Setup-score rank among Stage 2 peers: #1 of 18 in Medical Instruments & Supplies · #1 of 272 in Health Care

Is WST early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…
Stage Cycle Timeline2023-08-16 → 2026-10-22
S4 22w
S4 18w
S1 13w
S2 15w
S2 24w
2023-08-162026-10-22
S1S2S3S4Setup score (0–10, dashed line at 5)
S2 10w → S3 5w → S4 9w → S1 7w → S2 6w → S3 5w → S4 22w → S1 10w → S2 5w → S3 1w → S4 18w → S1 13w → S2 15w → S3 7w → S4 5w → S1 2w → S2 24w current
Total tracked: 165 weeks across 17 stage runs.

WST among Medical Instruments & Supplies5th of 51 by relative strength

All 51 →
Stocks in Medical Instruments & Supplies ranked by relative strength, with stage and one-month change
#StockStageRS1M
1PLSEStage 2 · wk 3498+1.3%
2PDEXStage 2 · wk 3697−13.3%
3HBIOStage 2 · wk 1195+3.6%
4ATRCStage 2 · wk 1089−1.1%
5WSTStage 2 · wk 2482+4.8%
6BDXStage 2 · wk 1181+9.8%
7ICUIStage 3 · wk 181+3.1%
8OSURStage 3 · wk 875−4.8%
vs 52W High
0.0%
$230.63 lo$394.03 hi
Near 52W high
How far this stock is from its 52-week high. A pullback of 3–20% while Stage 2 structure holds is typically a better entry than chasing near the high.
Stage Maturity
Week 24
1w13w26w
Week 24, proven structure
How long this stock has been in Stage 2. The sweet spot is mid-run: long enough to prove the structure holds, not so long that it's extended. Very fresh moves (weeks 1–4) often need more time to confirm.
vs 200 DMA
27.4%
200 DMA: $309.31 · rising
Long-term trend anchor. When the stock and the S&P 500 are both above their 200-day averages, the backdrop supports continuation.
Rel Volume
1.28x
vs 50-day avg
Low vol (0.5–1x) on pullbacks = resting, not being sold. High vol on breakouts = commitment. Volume spike on down days is a warning sign.
Trend Health
↗
Short-term trend rising gently
Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.
1M
+4.8%
3M
+20.1%
6M
+27.4%
YTD
+42.9%
1Y
+41.5%
Scan Membership
Breakout Watch
Latest: 2025-01-14
9 appearances in last 60 days. First seen: 2018-10-16.
A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding. Staying power in the scan says more about the trend than any single appearance.
Recent Stage Timeline
2026-10-22S2
Wk 24 · Vol 1.28x
2026-10-21S2
Wk 24 · Vol 1.05x
2026-10-20S2
Wk 24 · Vol 1.08x
2026-10-19S2
Wk 24 · Vol 0.59x
2026-10-16S2
Wk 23 · Vol 0.97x
2026-10-15S2
Wk 23 · Vol 0.73x
2026-10-14S2
Wk 23 · Vol 0.84x
2026-10-13S2
Wk 23 · Vol 0.95x
2026-10-12S2
Wk 23 · Vol 0.65x
2026-10-09S2
Wk 22 · Vol 0.87x
2026-10-08S2
Wk 22 · Vol 0.82x
2026-10-07S2
Wk 22 · Vol 0.77x
Moving averages & range
50 DMA
$361.15
200 DMA
$309.31
52W High
$394.03
52W Low
$230.63
5D Low
$383.91
Resistance levels (recent highs)
20d High
$394.03
60d High
$394.03
120d High
$394.03
250d High
$394.03
Next resistance
Above all
P/E (TTM)
50.5
Forward 39.4
Earnings Growth (YoY)
+18.1%
Revenue +13.8%
ROE
+19.1%
Profit margin +17.0%
Dividend Yield
0.26%
P/B 9.3

West Pharmaceutical Services: quick answers

What stage is West Pharmaceutical Services in?

As of Oct 22, 2026, West Pharmaceutical Services (WST) is in Stage 2, the uptrend phase. It entered Stage 2 on May 5, 2026 and is in week 24. What the four stages mean

Is West Pharmaceutical Services in an uptrend?

Yes. West Pharmaceutical Services is in a Stage 2 uptrend. It trades 27.4% above its 200-day average, which is rising.

How far is West Pharmaceutical Services from its 52-week high?

West Pharmaceutical Services closed at $394.03 on Oct 22, 2026, at its 52-week high. Its 52-week low is $230.63.

How has West Pharmaceutical Services performed over the past year?

As of Oct 22, 2026, West Pharmaceutical Services is up 41.5% over the past year and up 42.9% so far in 2026.

Which sector and industry is West Pharmaceutical Services in?

West Pharmaceutical Services is in the Medical Instruments & Supplies industry, part of the Health Care sector.

About this companyHealth Care· Medical Instruments & Supplies

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging products. This segment also provides drug containment solutions in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. This segment primarily serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.